X-154353704-C-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 3P and 4B. PP2PP3_ModerateBS2
The NM_001110556.2(FLNA):c.5710G>A(p.Gly1904Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000108 in 1,209,602 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 47 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001110556.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FLNA | NM_001110556.2 | c.5710G>A | p.Gly1904Ser | missense_variant | 36/48 | ENST00000369850.10 | NP_001104026.1 | |
FLNA | NM_001456.4 | c.5686G>A | p.Gly1896Ser | missense_variant | 35/47 | NP_001447.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FLNA | ENST00000369850.10 | c.5710G>A | p.Gly1904Ser | missense_variant | 36/48 | 1 | NM_001110556.2 | ENSP00000358866.3 |
Frequencies
GnomAD3 genomes AF: 0.0000531 AC: 6AN: 113013Hom.: 0 Cov.: 26 AF XY: 0.0000569 AC XY: 2AN XY: 35155
GnomAD3 exomes AF: 0.0000451 AC: 8AN: 177525Hom.: 0 AF XY: 0.0000313 AC XY: 2AN XY: 63907
GnomAD4 exome AF: 0.000114 AC: 125AN: 1096589Hom.: 0 Cov.: 33 AF XY: 0.000124 AC XY: 45AN XY: 362247
GnomAD4 genome AF: 0.0000531 AC: 6AN: 113013Hom.: 0 Cov.: 26 AF XY: 0.0000569 AC XY: 2AN XY: 35155
ClinVar
Submissions by phenotype
not provided Uncertain:4
Uncertain significance, no assertion criteria provided | provider interpretation | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Dec 21, 2016 | p.Gly1896Ser (c.5686G>A) in the FLNA gene (NM_001456.3) The lab classifies this variant as a variant of unknown significance. Given a lack of case data and presence in the general population we consider this variant a variant of unknown significance, likely benign and we do not feel it is suitable for assessing risk in healthy relatives ("predictive genetic testing"). The variant has not been reported in patients with aneurysm/dissection before. In silico analysis with PolyPhen-2 predicts the variant to be probably damaging (HumVar: 0.959). The Gly at codon 1896 is conserved across species, although there are a lot of species without a SMAD3 homolog. Other variants have been reported in association with disease at this codon or nearby codons. There are seven European (non-finnish) individuals out of 39,125 with variation at codon 1896 listed in the Genome Aggregation Consortium Dataset (gnomAD; http://gnomad.broadinstitute.org/), which corresponds to 1 in 5589 individuals in the dataset with this variant. There is also one individual with p.Gly1896Asp at that position. Of note, this patient also had a pathogenic SMAD3 variant that is the reason for his diagnosis of Loeys-Dietz syndrome. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 23, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jun 19, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2021 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jun 02, 2016 | - - |
Melnick-Needles syndrome;C0265293:Frontometaphyseal dysplasia;C1844696:Oto-palato-digital syndrome, type II;C1848213:Heterotopia, periventricular, X-linked dominant Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 17, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at